期刊文献+

西罗莫司在全血中的稳定性 被引量:1

The stability of sirolimus in whole blood
下载PDF
导出
摘要 目的:考察西罗莫司在全血中的稳定性。方法:配制浓度分别为2.5,7.5,22.5μg·L-1的西罗莫司血样,在3种温度下(25℃,4℃,-20℃)避光储存0~8d和在-40℃存放后经历3个冻融周期,考察西罗莫司在全血中的稳定性。结果:在3种温度下储存8d和经历3个冻融周期后,西罗莫司血药浓度无显著变化。结论:西罗莫司血样可在冰冻或室温条件保存8d,经历3个冻融周期后西罗莫司在全血中仍能保持稳定。 OBJECTIVETo investigate the stability of sirolimus in whole blood.METHODSAfter preparing sirolimus whole blood samples with concentration of (2.5)、(7.5)、(22.5) μg·L^(-1 ), the effects of storage time (0~8 days) under temperature of (25 ℃),(4 ℃), (-20 ℃) in dark, and freeze-thaw cycles under temperature of (-40 ℃) on the stability of sirolimus in whole blood were examined by HPLC. RESULTSAfter 8 days storage time and three freeze-thaw cycles, the concentration of sirolimus in whole blood had no significant difference. CONCLUSIONSirolimus was stable in whole blood under freeze or at room temperature after 8 days storage time. It was stable in whole blood after three freeze-thaw cycles, too.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2005年第6期532-534,共3页 Chinese Journal of Hospital Pharmacy
关键词 西罗莫司 稳定性 高效液相色谱法 sirolimus stability HPLC
  • 相关文献

参考文献5

二级参考文献11

  • 1Dumont F J,Life Sci,1996年,58卷,373页 被引量:1
  • 2Yatscoff R W,Ther apeutic Drug Monitorine,1995年,17卷,666页 被引量:1
  • 3Chen H F,Trans plantation,1993年,56卷,661页 被引量:1
  • 4Chung J,Cell,1992年,69卷,1227页 被引量:1
  • 5Satttler M,Drug Metab Dispos Biol Fate Chem,1992年,20卷,753页 被引量:1
  • 6Morris R E,Trans plant Proc,1990年,22卷,1638页 被引量:1
  • 7Siekierka J J,Nature,1989年,341卷,755页 被引量:1
  • 8David WH;Terry L;Kirsty J.Validation of an assay for routine monitoring of sirolimus using HPLC with mass spectrometric detection[J],2000(08). 被引量:1
  • 9Gabriele IK;Christian V;Wolfgang J.Simultaneous on-line extraction and analysis of sirolimus(rapamycin) and cyclosporin in blood by liquid chromatography-electrospray mass spectrometry[J],1999. 被引量:1
  • 10Paul JT;Anthony GJ.Quantitative analysis of sirolimus (rapamycin) in blood by highperformance liquid chromatography-electrospray tandem mass spectrometry[J],1998. 被引量:1

共引文献36

同被引文献16

  • 1彭明强,杨志豪,方自林.国内公开报道的肾移植后并发恶性肿瘤病例的总结分析[J].中华器官移植杂志,2005,26(5):269-271. 被引量:84
  • 2GAYA S B, REES A J, LECHLER R I, et al. Malignant disease in patients with long term renal transplants [ J ]. Transplantation, 1995, 59 (12) : 1705 - 1709. 被引量:1
  • 3SCHUMACHER G, OIDTMANN M, BAHRA M, et al. Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growth [ J ]. Transplant Proceeding, 2002, 34 ( 5 ) : 1392 - 1393. 被引量:1
  • 4LUAN F L, DING R, SHARMA V K, et al. Rapamycin is an effective inhibitor of human renal cancer metastasis [ J ]. Kidney Int, 2003, 63(3) :917 -926. 被引量:1
  • 5MATEO-LOZANO S, IIRADO O M, NOTARIO V. Rapamycin induces the fusion-type independent down regulation of the EWS/FLI-1 proteins and inhibits ewing's sarcoma cell proliferation [ J ]. Oncogene. 2003.22 ( 12 ) :9282 - 9287. 被引量:1
  • 6HASHEMOLHOSSEINI S, NAGAMINE Y, MORLEY S J, et al. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability[ J ]. Biol Chem, 1998, 273 (23) : 14424 - 14429. 被引量:1
  • 7NEUHAUS P, KLUPP J, LANGREHR J M. mTOR inhibitors: an overview [ J]. Liver Transplantation, 2001, 7 (6) : 473 - 483. 被引量:1
  • 8DENNIS P B, FUMAGALLI S, THOMAS G. Target of rapamycin (TOR) : balancing the opposing forces of protein synthesis and degradation[ J ]. Curr Opin Genet Dev, 1999, 9(1) : 49 -54. 被引量:1
  • 9KOEHL G, GUBA M, SEELIGER H, et al. Rapamycin treatment at immunosuppressive doses affects tumor blood vessel circulation [ J ]. Transplant Proceeding, 2003, 35 (6) :2135 -2136. 被引量:1
  • 10SENFFERLEIN T, ROZENGURT E. Rapamycin inhibits constitutive pT056k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells [ J ]. Cancer Res, 1996, 56(17) :3895 -3897. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部